When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these …
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Before …
Integra LifeSciences (IART) reported $382.65 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 3.7%. EPS of $0.41 for the same period compares to $0.55 a year ago. The reported revenue represents a surprise of +0.13% over the Zacks …
For the quarter ended March 2025, Ares Management (ARES) reported revenue of $897.58 million, up 21.9% over the same period last year. EPS came in at $1.09, compared to $0.80 in the year-ago quarter. The reported revenue represents a surprise of -1.76% over the …
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …
Zimmer Biomet (ZBH) reported $1.91 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.1%. EPS of $1.81 for the same period compares to $1.94 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.89 …
For the quarter ended March 2025, Cummins (CMI) reported revenue of $8.17 billion, down 2.7% over the same period last year. EPS came in at $5.96, compared to $5.10 in the year-ago quarter. The reported revenue represents a surprise of +1.33% over the Zacks …
After reaching an important support level, IBM (IBM) could be a good stock pick from a technical perspective. IBM surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend. The 50-day simple moving average is a widely used technical indicator that helps …
After reaching an important support level, Lam Research (LRCX) could be a good stock pick from a technical perspective. LRCX surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend. The 50-day simple moving average is a widely used technical indicator that …